Assessment of metabolic control and use of flash glucose monitoring systems in a cohort of pediatric, adolescents, and adults patients with Type 1 diabetes

Bahíllo‐Curieses, M. Pilar; Díaz-Soto, Gonzalo; Vidueira-Martínez, Ana Ma; Torres-Ballester, Irune; Gómez-Hoyos, Emilia; Luis-Román, Daniel de

doi:10.1007/s12020-021-02691-4

Cited by 13 publications

(9 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data from observational clinical studies in children aged 4–18 years at isCGM initiation have shown greater TIR 80 and lower HbA1c 80 , 81 compared to SMBG use prior to isCGM start, 80 , 81 similar to what has been described in adults. 82 , 83 , 84 Interestingly, when comparing isCGM users across different age groups, 85 , 86 benefits were more pronounced in children under 12 years 85 and preschool children 86 compared to adolescents 85 , 86 and adults. 85 Scanning frequency (11–13 scans/per day) is associated with favorable glycemic markers (HbA1c and TIR) though not with reduction of time in hypoglycemia.…”

Section: Continuous Glucose Monitoringmentioning

confidence: 98%

“… 85 Scanning frequency (11–13 scans/per day) is associated with favorable glycemic markers (HbA1c and TIR) though not with reduction of time in hypoglycemia. 80 , 81 , 85 , 87 , 88 These studies were all performed using first‐generation systems without alarms for impending hypo‐ and hyperglycemia. Studies using newer systems with optional real time alarms and improved accuracy are needed.…”

Section: Continuous Glucose Monitoringmentioning

confidence: 99%

“…Interestingly, when comparing isCGM users across different age groups, 85,86 benefits were more pronounced in children under 12 years 85 and preschool children 86 compared to adolescents 85,86 and adults 85 . Scanning frequency (11–13 scans/per day) is associated with favorable glycemic markers (HbA1c and TIR) though not with reduction of time in hypoglycemia 80,81,85,87,88 . These studies were all performed using first‐generation systems without alarms for impending hypo‐ and hyperglycemia.…”

Section: Continuous Glucose Monitoringmentioning

confidence: 99%

See 2 more Smart Citations

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

et al. 2022

View full text Add to dashboard Cite

Section: Continuous Glucose Monitoringmentioning

confidence: 98%

Section: Continuous Glucose Monitoringmentioning

confidence: 99%

Section: Continuous Glucose Monitoringmentioning

confidence: 99%

See 1 more Smart Citation

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

et al. 2022

View full text Add to dashboard Cite

“…19 Although reductions in glycosylated hemoglobin (HbA1c) were not seen in either of these two studies, smaller observational studies have shown notable improvements in both HbA1c and hypoglycemia. [20][21][22][23][24][25][26][27] In the absence of new randomized controlled studies with isCGM, there is currently no definitive evidence on the effects of these systems in reducing HbA1c levels. Furthermore, some experts believe that HbA1c is no longer the only parameter of interest in the follow-up of individuals with diabetes given the new metrics derived from CGM/ isCGM data analysis.…”

Section: Introductionmentioning

confidence: 99%

Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project

Ampudia‐Blasco

Ugarte-Abasolo

Chico

et al. 2022

J Diabetes Sci Technol

View full text Add to dashboard Cite

Background: Continuous glucose monitoring (CGM) systems are increasingly being adopted as an alternative or adjunct to self-monitoring of blood glucose (SMBG) by patients receiving insulin therapy. However, the available evidence on the role of intermittently scanned CGM or flash CGM (isCGM) remains limited. This consensus aims to evaluate the degree of agreement among Spanish experts on the role of isCGM in the evaluation of glycemic variability, reduction of glycosylated hemoglobin (HbA1c) levels, and selection and adjustment of insulin therapy. Methods: Delphi methodology was used to achieve consensus in two survey rounds. A total of 431 Spanish endocrinologists participated in the first round of a 34-item questionnaire survey on isCGM and 427 participated in the second round. Any disagreement was resolved in round 2. Results: Consensus was reached for 32 statements, and four items were ultimately agreed upon SMBG after round 2. There was a high degree of consensus that isCGM helps to evaluate glycemic variability, improves HbA1c levels, and can guide therapeutic changes in type 1 diabetes patients. However, there was no consensus on the routine use of the interquartile range to evaluate glycemic variability or the selection of HbA1c as the main parameter for monitoring glycemic control. Conclusions: Most Spanish experts believe that the isCGM system is appropriate for: (1) identifying glycemic variability and facilitating its management, (2) evaluating hyperglycemia as a complement of HbA1c levels, and (3) guiding therapeutic decisions on insulin selection and dosing. The isCGM system is a useful tool for patients and health care professionals to improve glycemic control in insulin-dependent diabetes.

show abstract

“…Self-monitoring blood glucose systems and continuous glucose monitoring systems are routinely preferred in diabetic children. 1 The FreeStyle® Libre™ Flash glucose monitoring system (Abbott Diabetes Care, Alameda, CA) has come as an entirely new concept in glucose monitoring by providing much greater data than blood glucose testing while being more affordable than the continuous glucose monitors. The FreeStyle Libre provides 'flash glucose monitoring' with glucose readings by scanning a sensor rather than pricking the patient's finger.…”

mentioning

confidence: 99%

Allergic Reaction Following Implantation of a Blood Glucose Sensor.

Atar

PİRGON

2021

J. Pediatr. Acad.

View full text Add to dashboard Cite

Increasing incidence and onset at a younger age has changed the treatment strategy of diabetes mellitus (DM) towards prevention, delaying the onset, and minimizing disease complications. Self-monitoring blood glucose systems and continuous glucose monitoring systems are routinely preferred in diabetic children.Flash glucose monitoring system has come as an entirely new concept in glucose monitoring by providing much greater data than blood glucose testing while being more affordable than the continuous glucose monitors. The FreeStyle Libre provides ‘flash glucose monitoring’ with glucose readings by scanning a sensor rather than pricking the patient’s finger. The sensor measures interstitial tissue glucose levels every minute via a disposable round sensor with a small catheter inserted under the skin that can be worn for up to 14 days. The entire system’s on-body sensor patch worn on the back of the upper arm is disposable. However, the mild erythema may occur on the skin and disappear spontaneously after 24 hours from the detachment of the sensor. Similar skin lesions were observed in diabetic patients, and there was moderate to severe itching in 0.5% of the cases and moderate erythema in 4% of cases

show abstract

Assessment of metabolic control and use of flash glucose monitoring systems in a cohort of pediatric, adolescents, and adults patients with Type 1 diabetes

Cited by 13 publications

References 20 publications

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project

Allergic Reaction Following Implantation of a Blood Glucose Sensor.

Contact Info

Product

Resources

About